vs
Side-by-side financial comparison of ATLANTIC AMERICAN CORP (AAME) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $53.8M, roughly 1.4× ATLANTIC AMERICAN CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 20.8%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $6.6M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 7.2%).
The Atlantic Telegraph Company was a company formed on 6 November 1856 to undertake and exploit a commercial telegraph cable across the Atlantic Ocean, the first such telecommunications link.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
AAME vs PBYI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $53.8M | $75.5M |
| Net Profit | $577.0K | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 1.4% | 22.7% |
| Net Margin | 1.1% | — |
| Revenue YoY | 20.8% | 27.7% |
| Net Profit YoY | 128.9% | — |
| EPS (diluted) | $0.02 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | $53.8M | $54.5M | ||
| Q2 25 | $55.3M | $52.4M | ||
| Q1 25 | $50.1M | $46.0M | ||
| Q4 24 | $49.0M | $59.1M | ||
| Q3 24 | $44.5M | $80.5M | ||
| Q2 24 | $47.7M | $47.1M | ||
| Q1 24 | $47.0M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $577.0K | $8.8M | ||
| Q2 25 | $3.3M | $5.9M | ||
| Q1 25 | $802.0K | $3.0M | ||
| Q4 24 | $412.0K | — | ||
| Q3 24 | $-2.0M | $20.3M | ||
| Q2 24 | $-684.0K | $-4.5M | ||
| Q1 24 | $-2.0M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | 1.4% | 17.6% | ||
| Q2 25 | 7.6% | 12.7% | ||
| Q1 25 | 2.1% | 8.7% | ||
| Q4 24 | 1.1% | 22.6% | ||
| Q3 24 | -5.5% | 27.4% | ||
| Q2 24 | -1.8% | -4.6% | ||
| Q1 24 | -5.3% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | 16.2% | ||
| Q2 25 | 6.0% | 11.2% | ||
| Q1 25 | 1.6% | 6.5% | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | -4.5% | 25.2% | ||
| Q2 24 | -1.4% | -9.6% | ||
| Q1 24 | -4.3% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.02 | $0.17 | ||
| Q2 25 | $0.15 | $0.12 | ||
| Q1 25 | $0.03 | $0.06 | ||
| Q4 24 | $0.01 | $0.40 | ||
| Q3 24 | $-0.10 | $0.41 | ||
| Q2 24 | $-0.04 | $-0.09 | ||
| Q1 24 | $-0.10 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.4M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $109.5M | $130.3M |
| Total Assets | $430.9M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | $34.4M | $94.4M | ||
| Q2 25 | $46.4M | $96.0M | ||
| Q1 25 | $35.9M | $93.2M | ||
| Q4 24 | $35.6M | $101.0M | ||
| Q3 24 | $23.0M | $96.7M | ||
| Q2 24 | $21.2M | $96.8M | ||
| Q1 24 | $21.2M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | $109.5M | $115.3M | ||
| Q2 25 | $106.2M | $104.7M | ||
| Q1 25 | $102.4M | $97.1M | ||
| Q4 24 | $99.6M | $92.1M | ||
| Q3 24 | $105.8M | $71.1M | ||
| Q2 24 | $100.7M | $48.5M | ||
| Q1 24 | $102.8M | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | $430.9M | $202.9M | ||
| Q2 25 | $429.3M | $194.9M | ||
| Q1 25 | $388.4M | $196.2M | ||
| Q4 24 | $393.4M | $213.3M | ||
| Q3 24 | $387.0M | $220.7M | ||
| Q2 24 | $386.0M | $205.0M | ||
| Q1 24 | $365.8M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | $14.4M |
| Free Cash FlowOCF − Capex | $6.6M | $14.4M |
| FCF MarginFCF / Revenue | 12.3% | 19.1% |
| Capex IntensityCapex / Revenue | 0.1% | 0.0% |
| Cash ConversionOCF / Net Profit | 11.51× | — |
| TTM Free Cash FlowTrailing 4 quarters | $19.3M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | $6.6M | $9.7M | ||
| Q2 25 | $9.3M | $14.1M | ||
| Q1 25 | $-722.0K | $3.6M | ||
| Q4 24 | $4.8M | $15.6M | ||
| Q3 24 | $90.0K | $11.0M | ||
| Q2 24 | $416.0K | $1.0M | ||
| Q1 24 | $-5.3M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | $6.6M | $9.7M | ||
| Q2 25 | $9.1M | $14.1M | ||
| Q1 25 | $-986.0K | $3.6M | ||
| Q4 24 | $4.6M | $15.6M | ||
| Q3 24 | $58.0K | $11.0M | ||
| Q2 24 | $361.0K | $1.0M | ||
| Q1 24 | $-5.4M | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | 12.3% | 17.7% | ||
| Q2 25 | 16.5% | 26.8% | ||
| Q1 25 | -2.0% | 7.7% | ||
| Q4 24 | 9.3% | 26.4% | ||
| Q3 24 | 0.1% | 13.7% | ||
| Q2 24 | 0.8% | 2.1% | ||
| Q1 24 | -11.4% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 0.5% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 11.51× | 1.10× | ||
| Q2 25 | 2.80× | 2.41× | ||
| Q1 25 | -0.90× | 1.21× | ||
| Q4 24 | 11.65× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAME
| Bankers Fidelity | $30.0M | 56% |
| American Southern | $23.7M | 44% |
PBYI
Segment breakdown not available.
